article thumbnail

Leading API biologics (protein and peptide) companies in contract marketing

Pharmaceutical Technology

More than 100 approved peptide-based therapeutics are currently available in the market. Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles.

Leads 52
article thumbnail

Handling HPAPIs safely – what does it take?

European Pharmaceutical Review

1 These substances “are pharmacologically and biologically active at low doses,” Dr Kishore Hotha, Global Head of Analytical Research & Development at Veranova, explained. He shared that the HPAPI market is expected to grow significantly in the next five years. What training is required for employees to handle HPAPIs safely?

Safety 87
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novo Nordisk, Kry partner on digital programme for obesity

pharmaphorum

The partners anticipate that the digital obesity programme will launch later this autumn in Sweden, ahead of a broader rollout in other European markets before the end of the year. It is estimated that more than half (53%) of the adults living in the EU are considered to be overweight or obese. billion in 2025.

article thumbnail

Why There's No Such Thing as a 'Safe' Drug?

Contrarian Sales Techniques

During my pharmacology class, I learned that there are no safe drugs, only safe patients. Clinical studies play an essential role in determining the safety and efficacy of new drugs before they can be approved for the public. This includes potential side effects or adverse reactions to medications.

article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.

Medical 81
article thumbnail

How NLP Helps Life Sciences Companies Unlock Insights from Drug Labels

PM360

When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Food and Drug Administration (FDA) or European Medicines Agency (EMA).

article thumbnail

Pfizer files blockbuster hope etrasimod for ulcerative colitis

pharmaphorum

The FDA and EMA have formally started their review of the drug, which analysts have suggested could become a $3 billion blockbuster for Pfizer if it reaches the market for UC and other immuno-inflammatory diseases. “We believe that etrasimod, if approved, has the potential to be a best-in-class, first-line advanced therapy.”